MICHAEL JACOBS: Open Payments
NPI 1710522313 · WAKE FOREST, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,084 in 40 payments from 14 companies in 2025. Trend: 2023 $173 · 2024 $829 · 2025 $1,084
Food & beverage: $1,084
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 10 | $285 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $198 |
| ABBVIE INC. | 9 | $162 |
| Teva Pharmaceuticals USA, Inc. | 3 | $90 |
| Vanda Pharmaceuticals Inc. | 2 | $69 |
| Lundbeck LLC | 2 | $54 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $40 |
| Vertical Pharmaceuticals, LLC | 2 | $37 |
| Corium, LLC | 1 | $31 |
| Janssen Pharmaceuticals, Inc | 1 | $29 |
Products named: REXULTI, CAPLYTA, VRAYLAR, HETLIOZ, UZEDY, TRINTELLIX, Relexxii, Azstarys.
Industry payments across NC — which companies pay providers there.
